32073739|t|A TREML2 missense variant influences specific hippocampal subfield volumes in cognitively normal elderly subjects.
32073739|a|INTRODUCTION: Triggering receptor expressed on myeloid cells-like transcript 2 gene (TREML2) is a newly identified AD susceptibility gene. Its missense variant rs3747742-C substantially decreases AD risk in both Caucasians and Han Chinese, but the underlying mechanisms remain elusive. In the present study, to uncover the possible mechanisms by which TREML2 rs3747742-C reduces AD risk, we investigated the possible relation of this variant with AD-related brain structures using a cognitively normal elderly population from Alzheimer's Disease Neuroimaging Initiative (ADNI) database. METHODS: In total, 158 cognitively normal elders from ADNI database with complete data for brain structures and TREML2 rs3747742 genotype were included in this study. The association of TREML2 rs3747742 genotype with the structures of three cerebral cortices (entorhinal cortex, middle temporal gyrus, and parahippocampal gyrus), two subcortical regions (amygdala and hippocampus), and three subfields of hippocampus (CA1, CA2 + CA3, and CA4 + dentate gyrus) was investigated. RESULTS: A significant difference was noted in the volume of right CA1 subfield among three genotypes of TREML2 rs3747742 (p = .0364). In the multivariate analysis, TREML2 rs3747742-C significantly increased right CA1 subfield volume after adjusting for age, gender, education years, APOE epsilon4 status, and intracranial volume under the recessive genetic model (Bonferroni corrected p = .003586). CONCLUSION: The present study provides the first evidence that TREML2 rs3747742-C carriers have larger volumes of hippocampal CA1 subfield in a cognitively normal elderly population. These findings imply that enhancement of brain reserve may contribute to the protection of TREML2 rs3747742-C in AD susceptibility.
32073739	2	8	TREML2	Gene	79865
32073739	200	206	TREML2	Gene	79865
32073739	230	232	AD	Disease	MESH:D000544
32073739	275	284	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	311	313	AD	Disease	MESH:D000544
32073739	467	473	TREML2	Gene	79865
32073739	474	483	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	494	496	AD	Disease	MESH:D000544
32073739	562	564	AD	Disease	MESH:D000544
32073739	641	660	Alzheimer's Disease	Disease	MESH:D000544
32073739	814	820	TREML2	Gene	79865
32073739	821	830	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	888	894	TREML2	Gene	79865
32073739	895	904	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	1284	1290	TREML2	Gene	79865
32073739	1291	1300	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	1344	1350	TREML2	Gene	79865
32073739	1351	1360	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	1463	1467	APOE	Gene	348
32073739	1642	1648	TREML2	Gene	79865
32073739	1649	1658	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	1853	1859	TREML2	Gene	79865
32073739	1860	1869	rs3747742	SNP	tmVar:rs3747742;VariantGroup:0;CorrespondingGene:79865;RS#:3747742;CorrespondingSpecies:9606
32073739	1875	1877	AD	Disease	MESH:D000544
32073739	Negative_Correlation	MESH:D000544	RS#:3747742;CorrespondingGene:79865
32073739	Association	MESH:D000544	79865
32073739	Association	MESH:D000544	79865

